世界のインテグリンアルファV市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Integrin Alpha V Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5804
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、インテグリンアルファVの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（MK-0429、C-16Y、264-RAD、AC-301、その他）、用途別市場規模（代謝性疾患、眼科、呼吸器、感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・インテグリンアルファVの市場動向
・企業の競争状況、市場シェア
・インテグリンアルファVの種類別市場規模と予測2016-2027（MK-0429、C-16Y、264-RAD、AC-301、その他）
・インテグリンアルファVの用途別市場規模と予測2016-2027（代謝性疾患、眼科、呼吸器、感染症、その他）
・インテグリンアルファVの北米市場規模2016-2027（アメリカ、カナダ）
・インテグリンアルファVの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・インテグリンアルファVのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・インテグリンアルファVの中南米市場規模2016-2027（メキシコ、ブラジル）
・インテグリンアルファVの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Biogen Inc、BioMAS Ltd、Factor Therapeutics Ltd、MedImmune LLC、Merck & Co Inc、Merck KGaA、Morphic Therapeutic Inc、SciFluor Life Sciences LLC、Vascular Pharmaceuticals Inc）
・結論

Market Analysis and Insights: Global Integrin Alpha V Market
The global Integrin Alpha V market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Integrin Alpha V market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Integrin Alpha V market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Integrin Alpha V market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Integrin Alpha V market.

Global Integrin Alpha V Scope and Market Size
Integrin Alpha V market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Integrin Alpha V market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
MK-0429
C-16Y
264-RAD
AC-301
Others

Segment by Application
Metabolic Disorders
Ophthalmology
Respiratory
Infectious Disease
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biogen Inc
BioMAS Ltd
Factor Therapeutics Ltd
MedImmune LLC
Merck & Co Inc
Merck KGaA
Morphic Therapeutic Inc
SciFluor Life Sciences LLC
Vascular Pharmaceuticals Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Integrin Alpha V Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 MK-0429
1.2.3 C-16Y
1.2.4 264-RAD
1.2.5 AC-301
1.2.6 Others
1.3 Market by Application
1.3.1 Global Integrin Alpha V Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Metabolic Disorders
1.3.3 Ophthalmology
1.3.4 Respiratory
1.3.5 Infectious Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Integrin Alpha V Market Perspective (2016-2027)
2.2 Integrin Alpha V Growth Trends by Regions
2.2.1 Integrin Alpha V Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Integrin Alpha V Historic Market Share by Regions (2016-2021)
2.2.3 Integrin Alpha V Forecasted Market Size by Regions (2022-2027)
2.3 Integrin Alpha V Industry Dynamic
2.3.1 Integrin Alpha V Market Trends
2.3.2 Integrin Alpha V Market Drivers
2.3.3 Integrin Alpha V Market Challenges
2.3.4 Integrin Alpha V Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Integrin Alpha V Players by Revenue
3.1.1 Global Top Integrin Alpha V Players by Revenue (2016-2021)
3.1.2 Global Integrin Alpha V Revenue Market Share by Players (2016-2021)
3.2 Global Integrin Alpha V Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Integrin Alpha V Revenue
3.4 Global Integrin Alpha V Market Concentration Ratio
3.4.1 Global Integrin Alpha V Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Integrin Alpha V Revenue in 2020
3.5 Integrin Alpha V Key Players Head office and Area Served
3.6 Key Players Integrin Alpha V Product Solution and Service
3.7 Date of Enter into Integrin Alpha V Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Integrin Alpha V Breakdown Data by Type
4.1 Global Integrin Alpha V Historic Market Size by Type (2016-2021)
4.2 Global Integrin Alpha V Forecasted Market Size by Type (2022-2027)

5 Integrin Alpha V Breakdown Data by Application
5.1 Global Integrin Alpha V Historic Market Size by Application (2016-2021)
5.2 Global Integrin Alpha V Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Integrin Alpha V Market Size (2016-2027)
6.2 North America Integrin Alpha V Market Size by Type
6.2.1 North America Integrin Alpha V Market Size by Type (2016-2021)
6.2.2 North America Integrin Alpha V Market Size by Type (2022-2027)
6.2.3 North America Integrin Alpha V Market Size by Type (2016-2027)
6.3 North America Integrin Alpha V Market Size by Application
6.3.1 North America Integrin Alpha V Market Size by Application (2016-2021)
6.3.2 North America Integrin Alpha V Market Size by Application (2022-2027)
6.3.3 North America Integrin Alpha V Market Size by Application (2016-2027)
6.4 North America Integrin Alpha V Market Size by Country
6.4.1 North America Integrin Alpha V Market Size by Country (2016-2021)
6.4.2 North America Integrin Alpha V Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Integrin Alpha V Market Size (2016-2027)
7.2 Europe Integrin Alpha V Market Size by Type
7.2.1 Europe Integrin Alpha V Market Size by Type (2016-2021)
7.2.2 Europe Integrin Alpha V Market Size by Type (2022-2027)
7.2.3 Europe Integrin Alpha V Market Size by Type (2016-2027)
7.3 Europe Integrin Alpha V Market Size by Application
7.3.1 Europe Integrin Alpha V Market Size by Application (2016-2021)
7.3.2 Europe Integrin Alpha V Market Size by Application (2022-2027)
7.3.3 Europe Integrin Alpha V Market Size by Application (2016-2027)
7.4 Europe Integrin Alpha V Market Size by Country
7.4.1 Europe Integrin Alpha V Market Size by Country (2016-2021)
7.4.2 Europe Integrin Alpha V Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Integrin Alpha V Market Size (2016-2027)
8.2 Asia-Pacific Integrin Alpha V Market Size by Type
8.2.1 Asia-Pacific Integrin Alpha V Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Integrin Alpha V Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Integrin Alpha V Market Size by Type (2016-2027)
8.3 Asia-Pacific Integrin Alpha V Market Size by Application
8.3.1 Asia-Pacific Integrin Alpha V Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Integrin Alpha V Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Integrin Alpha V Market Size by Application (2016-2027)
8.4 Asia-Pacific Integrin Alpha V Market Size by Region
8.4.1 Asia-Pacific Integrin Alpha V Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Integrin Alpha V Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Integrin Alpha V Market Size (2016-2027)
9.2 Latin America Integrin Alpha V Market Size by Type
9.2.1 Latin America Integrin Alpha V Market Size by Type (2016-2021)
9.2.2 Latin America Integrin Alpha V Market Size by Type (2022-2027)
9.2.3 Latin America Integrin Alpha V Market Size by Type (2016-2027)
9.3 Latin America Integrin Alpha V Market Size by Application
9.3.1 Latin America Integrin Alpha V Market Size by Application (2016-2021)
9.3.2 Latin America Integrin Alpha V Market Size by Application (2022-2027)
9.3.3 Latin America Integrin Alpha V Market Size by Application (2016-2027)
9.4 Latin America Integrin Alpha V Market Size by Country
9.4.1 Latin America Integrin Alpha V Market Size by Country (2016-2021)
9.4.2 Latin America Integrin Alpha V Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Integrin Alpha V Market Size (2016-2027)
10.2 Middle East & Africa Integrin Alpha V Market Size by Type
10.2.1 Middle East & Africa Integrin Alpha V Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Integrin Alpha V Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Integrin Alpha V Market Size by Type (2016-2027)
10.3 Middle East & Africa Integrin Alpha V Market Size by Application
10.3.1 Middle East & Africa Integrin Alpha V Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Integrin Alpha V Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Integrin Alpha V Market Size by Application (2016-2027)
10.4 Middle East & Africa Integrin Alpha V Market Size by Country
10.4.1 Middle East & Africa Integrin Alpha V Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Integrin Alpha V Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biogen Inc
11.1.1 Biogen Inc Company Details
11.1.2 Biogen Inc Business Overview
11.1.3 Biogen Inc Integrin Alpha V Introduction
11.1.4 Biogen Inc Revenue in Integrin Alpha V Business (2016-2021)
11.1.5 Biogen Inc Recent Development
11.2 BioMAS Ltd
11.2.1 BioMAS Ltd Company Details
11.2.2 BioMAS Ltd Business Overview
11.2.3 BioMAS Ltd Integrin Alpha V Introduction
11.2.4 BioMAS Ltd Revenue in Integrin Alpha V Business (2016-2021)
11.2.5 BioMAS Ltd Recent Development
11.3 Factor Therapeutics Ltd
11.3.1 Factor Therapeutics Ltd Company Details
11.3.2 Factor Therapeutics Ltd Business Overview
11.3.3 Factor Therapeutics Ltd Integrin Alpha V Introduction
11.3.4 Factor Therapeutics Ltd Revenue in Integrin Alpha V Business (2016-2021)
11.3.5 Factor Therapeutics Ltd Recent Development
11.4 MedImmune LLC
11.4.1 MedImmune LLC Company Details
11.4.2 MedImmune LLC Business Overview
11.4.3 MedImmune LLC Integrin Alpha V Introduction
11.4.4 MedImmune LLC Revenue in Integrin Alpha V Business (2016-2021)
11.4.5 MedImmune LLC Recent Development
11.5 Merck & Co Inc
11.5.1 Merck & Co Inc Company Details
11.5.2 Merck & Co Inc Business Overview
11.5.3 Merck & Co Inc Integrin Alpha V Introduction
11.5.4 Merck & Co Inc Revenue in Integrin Alpha V Business (2016-2021)
11.5.5 Merck & Co Inc Recent Development
11.6 Merck KGaA
11.6.1 Merck KGaA Company Details
11.6.2 Merck KGaA Business Overview
11.6.3 Merck KGaA Integrin Alpha V Introduction
11.6.4 Merck KGaA Revenue in Integrin Alpha V Business (2016-2021)
11.6.5 Merck KGaA Recent Development
11.7 Morphic Therapeutic Inc
11.7.1 Morphic Therapeutic Inc Company Details
11.7.2 Morphic Therapeutic Inc Business Overview
11.7.3 Morphic Therapeutic Inc Integrin Alpha V Introduction
11.7.4 Morphic Therapeutic Inc Revenue in Integrin Alpha V Business (2016-2021)
11.7.5 Morphic Therapeutic Inc Recent Development
11.8 SciFluor Life Sciences LLC
11.8.1 SciFluor Life Sciences LLC Company Details
11.8.2 SciFluor Life Sciences LLC Business Overview
11.8.3 SciFluor Life Sciences LLC Integrin Alpha V Introduction
11.8.4 SciFluor Life Sciences LLC Revenue in Integrin Alpha V Business (2016-2021)
11.8.5 SciFluor Life Sciences LLC Recent Development
11.9 Vascular Pharmaceuticals Inc
11.9.1 Vascular Pharmaceuticals Inc Company Details
11.9.2 Vascular Pharmaceuticals Inc Business Overview
11.9.3 Vascular Pharmaceuticals Inc Integrin Alpha V Introduction
11.9.4 Vascular Pharmaceuticals Inc Revenue in Integrin Alpha V Business (2016-2021)
11.9.5 Vascular Pharmaceuticals Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Integrin Alpha V Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of MK-0429
Table 3. Key Players of C-16Y
Table 4. Key Players of 264-RAD
Table 5. Key Players of AC-301
Table 6. Key Players of Others
Table 7. Global Integrin Alpha V Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Integrin Alpha V Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Integrin Alpha V Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Integrin Alpha V Market Share by Regions (2016-2021)
Table 11. Global Integrin Alpha V Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Integrin Alpha V Market Share by Regions (2022-2027)
Table 13. Integrin Alpha V Market Trends
Table 14. Integrin Alpha V Market Drivers
Table 15. Integrin Alpha V Market Challenges
Table 16. Integrin Alpha V Market Restraints
Table 17. Global Integrin Alpha V Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Integrin Alpha V Market Share by Players (2016-2021)
Table 19. Global Top Integrin Alpha V Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Integrin Alpha V as of 2020)
Table 20. Ranking of Global Top Integrin Alpha V Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Integrin Alpha V Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Integrin Alpha V Product Solution and Service
Table 24. Date of Enter into Integrin Alpha V Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Integrin Alpha V Revenue Market Share by Type (2016-2021)
Table 28. Global Integrin Alpha V Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Integrin Alpha V Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Integrin Alpha V Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Integrin Alpha V Revenue Market Share by Application (2016-2021)
Table 32. Global Integrin Alpha V Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Integrin Alpha V Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Integrin Alpha V Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Integrin Alpha V Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Integrin Alpha V Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Integrin Alpha V Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Integrin Alpha V Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Integrin Alpha V Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Integrin Alpha V Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Integrin Alpha V Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Integrin Alpha V Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Integrin Alpha V Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Integrin Alpha V Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Integrin Alpha V Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Integrin Alpha V Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Integrin Alpha V Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Integrin Alpha V Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Integrin Alpha V Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Integrin Alpha V Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Integrin Alpha V Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Integrin Alpha V Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Integrin Alpha V Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Integrin Alpha V Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Integrin Alpha V Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Integrin Alpha V Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Integrin Alpha V Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Integrin Alpha V Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Integrin Alpha V Market Size by Country (2022-2027) & (US$ Million)
Table 64. Biogen Inc Company Details
Table 65. Biogen Inc Business Overview
Table 66. Biogen Inc Integrin Alpha V Product
Table 67. Biogen Inc Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 68. Biogen Inc Recent Development
Table 69. BioMAS Ltd Company Details
Table 70. BioMAS Ltd Business Overview
Table 71. BioMAS Ltd Integrin Alpha V Product
Table 72. BioMAS Ltd Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 73. BioMAS Ltd Recent Development
Table 74. Factor Therapeutics Ltd Company Details
Table 75. Factor Therapeutics Ltd Business Overview
Table 76. Factor Therapeutics Ltd Integrin Alpha V Product
Table 77. Factor Therapeutics Ltd Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 78. Factor Therapeutics Ltd Recent Development
Table 79. MedImmune LLC Company Details
Table 80. MedImmune LLC Business Overview
Table 81. MedImmune LLC Integrin Alpha V Product
Table 82. MedImmune LLC Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 83. MedImmune LLC Recent Development
Table 84. Merck & Co Inc Company Details
Table 85. Merck & Co Inc Business Overview
Table 86. Merck & Co Inc Integrin Alpha V Product
Table 87. Merck & Co Inc Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 88. Merck & Co Inc Recent Development
Table 89. Merck KGaA Company Details
Table 90. Merck KGaA Business Overview
Table 91. Merck KGaA Integrin Alpha V Product
Table 92. Merck KGaA Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 93. Merck KGaA Recent Development
Table 94. Morphic Therapeutic Inc Company Details
Table 95. Morphic Therapeutic Inc Business Overview
Table 96. Morphic Therapeutic Inc Integrin Alpha V Product
Table 97. Morphic Therapeutic Inc Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 98. Morphic Therapeutic Inc Recent Development
Table 99. SciFluor Life Sciences LLC Company Details
Table 100. SciFluor Life Sciences LLC Business Overview
Table 101. SciFluor Life Sciences LLC Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 102. SciFluor Life Sciences LLC Recent Development
Table 103. Vascular Pharmaceuticals Inc Company Details
Table 104. Vascular Pharmaceuticals Inc Business Overview
Table 105. Vascular Pharmaceuticals Inc Integrin Alpha V Product
Table 106. Vascular Pharmaceuticals Inc Revenue in Integrin Alpha V Business (2016-2021) & (US$ Million)
Table 107. Vascular Pharmaceuticals Inc Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Integrin Alpha V Market Share by Type: 2020 VS 2027
Figure 2. MK-0429 Features
Figure 3. C-16Y Features
Figure 4. 264-RAD Features
Figure 5. AC-301 Features
Figure 6. Others Features
Figure 7. Global Integrin Alpha V Market Share by Application: 2020 VS 2027
Figure 8. Metabolic Disorders Case Studies
Figure 9. Ophthalmology Case Studies
Figure 10. Respiratory Case Studies
Figure 11. Infectious Disease Case Studies
Figure 12. Others Case Studies
Figure 13. Integrin Alpha V Report Years Considered
Figure 14. Global Integrin Alpha V Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Integrin Alpha V Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Integrin Alpha V Market Share by Regions: 2020 VS 2027
Figure 17. Global Integrin Alpha V Market Share by Regions (2022-2027)
Figure 18. Global Integrin Alpha V Market Share by Players in 2020
Figure 19. Global Top Integrin Alpha V Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Integrin Alpha V as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Integrin Alpha V Revenue in 2020
Figure 21. Global Integrin Alpha V Revenue Market Share by Type (2016-2021)
Figure 22. Global Integrin Alpha V Revenue Market Share by Type (2022-2027)
Figure 23. North America Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Integrin Alpha V Market Share by Type (2016-2027)
Figure 25. North America Integrin Alpha V Market Share by Application (2016-2027)
Figure 26. North America Integrin Alpha V Market Share by Country (2016-2027)
Figure 27. United States Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Integrin Alpha V Market Share by Type (2016-2027)
Figure 31. Europe Integrin Alpha V Market Share by Application (2016-2027)
Figure 32. Europe Integrin Alpha V Market Share by Country (2016-2027)
Figure 33. Germany Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Integrin Alpha V Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Integrin Alpha V Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Integrin Alpha V Market Share by Region (2016-2027)
Figure 43. China Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Integrin Alpha V Market Share by Type (2016-2027)
Figure 51. Latin America Integrin Alpha V Market Share by Application (2016-2027)
Figure 52. Latin America Integrin Alpha V Market Share by Country (2016-2027)
Figure 53. Mexico Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Integrin Alpha V Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Integrin Alpha V Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Integrin Alpha V Market Share by Country (2016-2027)
Figure 59. Turkey Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Integrin Alpha V Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Biogen Inc Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 63. BioMAS Ltd Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 64. Factor Therapeutics Ltd Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 65. MedImmune LLC Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 66. Merck & Co Inc Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 67. Merck KGaA Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 68. Morphic Therapeutic Inc Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 69. SciFluor Life Sciences LLC Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 70. Vascular Pharmaceuticals Inc Revenue Growth Rate in Integrin Alpha V Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年）

Global Alpha 2C Adrenergic Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5572 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、α2Cアドレナリン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラクリペップ、JNJ-4789、SKL-PSY、その他）、用途別市場規模（双極性障害、ドライアイ、大うつ病、その他）、主要地域別...

世界のα1アンチトリプシン欠乏症増強療法市場規模・現状・予測（2021年-2027年）

Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, Status and Forecast 2021-2027
QFJ1-3783 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、α1アンチトリプシン欠乏症増強療法の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（グラシア、アララストNP、プロラスチンC、その他）、用途別市場規模（病院、専門診療所）、主要地域別市場規模（北米、アメ...

世界のαサラセミア治療市場規模・現状・予測（2021年-2027年）

Global Alpha Thalassemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3782 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、αサラセミア治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（葉酸、デフェラシロクス、デフェリプロン、ヒドロキシ尿素）、用途別市場規模（病院、外来外科センター、その他）、主要地域別市場規模（北米、ア...

世界の植物組織培養市場規模・現状・予測（2021年-2027年）

Global Plant Tissue Culture Market Size, Status and Forecast 2021-2027
QFJ1-4713 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、植物組織培養の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、試薬、機器）、用途別市場規模（農業、科学研究、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の鎌状赤血球症診断市場規模・現状・予測（2021年-2027年）

Global Sickle Cell Disease Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4861 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、鎌状赤血球症診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（検査サービス、検査キット）、用途別市場規模（新生児、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のAATテスト市場規模・現状・予測（2021年-2027年）

Global AAT Test Market Size, Status and Forecast 2021-2027
QFJ1-3747 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、AATテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（病院＆診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の植物組織培養製品市場規模・現状・予測（2021年-2027年）

Global Plant Tissue Culture Products Market Size, Status and Forecast 2021-2027
QFJ1-4714 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、植物組織培養製品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、試薬、機器）、用途別市場規模（農業、科学研究、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のGOTテスト市場規模・現状・予測（2021年-2027年）

Global GOT Test Market Size, Status and Forecast 2021-2027
QFJ1-4270 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、GOTテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（金融商品、消耗品、その他）、用途別市場規模（病院＆診療所、診断用ラボ、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のASAT検査市場規模・現状・予測（2021年-2027年）

Global ASAT Test Market Size, Status and Forecast 2021-2027
QFJ1-3861 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、ASAT検査の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、消耗品、その他）、用途別市場規模（病院＆診療所、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓...

世界の血液代替物市場規模・現状・予測（2021年-2027年）

Global Blood Surrogates Market Size, Status and Forecast 2021-2027
QFJ1-3921 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、血液代替物の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（HBOC、PFBOC）、用途別市場規模（病院、診療所、研究機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

インテグリンベータ1のグローバル市場調査 2019年 The global Integrin Beta 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Integrin Beta 1 volume and value at global level, regional level and company level. From a global perspective, this report …
インテグリンベータ3のグローバル市場調査 2019年 The global Integrin Beta 3 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Integrin Beta 3 volume and value at global level, regional level and company level. From a global perspective, this report …
世界の感染症治療薬市場規模・現状・予測（2021年-2027年） Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission. The epidemic of infectious diseases has risen, spending has increased to increase the penetration of treatments for these diseases, initiatives to increase treatment awareness and awarenes…
世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Alpha 2C Adrenergic Receptor Market The global Alpha 2C Adrenergic Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…
世界の小児呼吸器疾患治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Pediatric Respiratory Disease Therapeutics Market The global Pediatric Respiratory Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in an…